ArticleEClinicalMedicine2024

GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study.

Hannah Moll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.